(Press-News.org) A team of 50 leading international experts, the Lancet Commission on Investing in Health (CIH), explored this question, resulting in clear, actionable, and achievable measures for achieving this ambitious goal worldwide. Six of the 50 commission members are affiliated with the Bergen Centre for Ethics and Priority Setting in Health (BCEPS), a Norwegian Centre of Excellence based at the University of Bergen, Norway, including BCEPS Director and Professor Ole Frithjof Norheim, BCEPS PhD Research Fellow Sarah Bolongaita, and BCEPS-affiliated researchers Angela Chang (University of Southern Denmark), Dean T. Jamison (University of California, San Francisco), Stéphane Verguet (Harvard University), and David Watkins (University of Washington).
Their report will be released on Tuesday, October 15, 2024, when CIH members will give a keynote presentation of their findings at the World Health Summit in Berlin, Germany.
The report will be freely available to the public at https://globalhealth2050.org, and the presentation given at the World Health Summit on October 15, 2024, from 4 pm - 5:30 pm CET, can be viewed online at https://www.youtube.com/watch?v=oHl-BLsfNF0.
According to the authors, the “50 by 50” goal, a 50% reduction in the probability of premature death (death before age 70), can be achieved by focusing on 15 priority conditions, eight related to infectious diseases and maternal health and seven related to non-communicable diseases and injuries.
Besides the scale-up of investments and services for these 15 priority health conditions, raising taxes on tobacco can do more to reduce premature mortality than any other single health policy.
In addition, the report estimates that there is a greater than 20% chance in the next 10 years of a pandemic that kills at least 25 million people—a magnitude similar to that of the COVID-19 pandemic, making pandemic preparedness and response critical.
The Global Health 2050 report offers a pathway for high-, middle- and low-income nations to drastically improve human welfare and life expectancy by 2050.
END
50 by 50—How can we reduce the probability of dying before age 70 by 50% globally by 2050?
2024-10-14
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Research explains why some cyclists don’t wear helmets and what might convince them to wear one
2024-10-14
Copenhagen, Denmark: Wearing a helmet can prevent brain injury and deaths in cyclists, yet many do not wear a helmet. New research presented at the European Emergency Medicine Congress today (Tuesday) suggests that this is largely due to issues of convenience and comfort. [1]
The study also suggests that more adult cyclists would wear helmets if they were encouraged and incentivised to do so, for example if they were provided with a free helmet, education, and periodic reminders.
The research was presented by Dr Steven Friedman, an emergency doctor at Toronto General Hospital and associate professor at the University ...
Half of all patients with sepsis die within two years
2024-10-14
Copenhagen, Denmark: Half of all patients with sepsis admitted to an emergency medical department died within two years, according to Danish researchers investigating factors that could predict outcomes for these patients.
Dr Finn E. Nielsen, a senior scientist in the Department of Clinical Epidemiology at Aarhus University Hospital, Denmark, told the European Emergency Medicine Congress today (Tuesday) [1] that he and his colleagues examined deaths over a long follow-up period in a prospective study of 714 adult patients admitted to the emergency department with sepsis. Their findings ...
Native Hawaiian and Pacific Islander adults have third highest cardiovascular death rate in the U.S.
2024-10-14
Embargoed for release until 5:00 p.m. ET on Monday 14 October 2024
@Annalsofim
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent. ...
Gene therapy automatically converts omega-6 to omega-3 fatty acids in the body
2024-10-14
St. Louis, MO (October 14, 2024) According to the Centers for Disease Control, nearly 20% of children and teens are considered obese. Research shows it can have a dramatic impact on a variety of health conditions, including arthritis, heart conditions and other metabolic problems, and the American Academy of Pediatrics now recommends early and intensive treatment to combat obesity. Over the last four years, Shriners Children’s St. Louis researchers have been working to develop a new way to prevent the effects of childhood obesity.
Using gene therapy, Shriners Children’s St. Louis Director of Research Dr. Farshid Guilak and Senior Scientist Dr. Ruhang Tang ...
Mpox clinical presentation, diagnostic approaches, and treatment strategies
2024-10-14
About The Study: Mpox is a viral infection transmitted primarily through close skin to skin contact that typically causes a self-resolving illness but can result in severe illness and death in immunocompromised individuals. First-line therapy is supportive care, although patients with severe mpox infection may be treated with advanced therapeutics. Mpox vaccination is effective and, if available, should be offered to individuals at risk of exposure to mpox.
Corresponding Author: To contact the corresponding author, Jason Zucker, MD, MS, email Jz2700@cumc.columbia.edu.
To access the embargoed study: Visit our For The Media ...
Trends in oral and injectable HIV preexposure prophylaxis prescriptions in the US
2024-10-14
About The Study: Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, with generic tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) being the most frequently prescribed medication since 2021. Injectable PrEP use was low likely because of barriers such as the high cost of stocking this expensive medication in clinics.
Corresponding Author: To contact the corresponding author, Laura M. Mann, PhD, MPH, email lmann@cdc.gov.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.21493)
Editor’s ...
Information about sexual and gender minority services and policies on US hospital websites
2024-10-14
About The Study: Most U.S. hospital websites explicitly included sexual and gender minority (SGM) populations in their nondiscrimination policies, but only a quarter of adult hospitals had an SGM-friendly clinician directory and provided information about SGM-related resources or hospital-based services. Pediatric hospitals more frequently posted SGM-related information than adult hospitals. Hospitals in states with more discriminatory policies were less likely to provide SGM-related information online.
Corresponding Author: To contact the corresponding author, Alex S. Keuroghlian, MD, MPH, email akeuroghlian@mgb.org.
To ...
Study finds use of naloxone by Good Samaritans is up, but not nearly enough
2024-10-14
Study finds use of naloxone by Good Samaritans is up, but not nearly enough
Ohio State and National Registry of EMTs research highlights importance of public’s help in opioid overdose response
COLUMBUS, Ohio – Use of a lifesaving drug to reverse opioid drug overdoses is growing, but not fast enough. That’s according to new research in JAMA Network Open from The Ohio State University College of Medicine, College of Public Health and the National Registry of Emergency Medical Technicians.
In the first study of its kind, the research team looked at national use of naloxone by people without medical training to treat an opioid drug overdose.
“Naloxone ...
Risk of suicidal ideation or attempts in adolescents with obesity treated with GLP1 receptor agonists
2024-10-14
About The Study: In this study, adolescents with obesity prescribed a glucagon-like peptide 1 receptor agonists (GLP1R) had a lower incidence of suicidal ideation or attempts compared with matched patients not prescribed GLP1R who were treated with lifestyle intervention. These results suggest a favorable psychiatric safety profile of GLP1R in adolescents. The detected reduction in hazard ratios for suicidal ideation among adolescents with obesity prescribed GLP1R suggests potential avenues for future research.
Corresponding Author: To contact the corresponding author, Liya Kerem, MD, MSc, email liya.em@gmail.com.
To access the ...
SARS-CoV-2 infection and new-onset type 2 diabetes among pediatric patients
2024-10-14
About The Study: In this retrospective cohort study of children and adolescents ages 10 to 19, the risk of an incident diagnosis of type 2 diabetes was greater following a COVID-19 diagnosis than in children diagnosed with other respiratory infections. Further study is required to determine whether diabetes persists or reverses later in life.
Corresponding Author: To contact the corresponding author, Pauline Terebuh, MD, MPH, email pdt@case.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.39444)
Editor’s Note: Please see the article for additional information, ...